Alvotech (ALVO) Depreciation & Amortization (CF) (2021 - 2025)
Alvotech (ALVO) reported Depreciation & Amortization (CF) of $10.4 million for Q4 2025, up 27.69% on a YoY basis from $8.2 million in Q4 2024, and up 1.27% quarter-over-quarter from $10.3 million in Q3 2025.
Alvotech (ALVO) Depreciation & Amortization (CF) (2021 - 2025) Analysis & Trends
Alvotech has reported Depreciation & Amortization (CF) for 5 years, with the latest figure at $10.4 million in Q4 2025.
- For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 27.69% year-over-year to $10.4 million; the trailing twelve-month figure through Dec 2025 stood at $37.9 million (up 20.93% YoY), and the FY2025 full-year result was $37.9 million, up 20.93% from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 stood at $10.4 million, up from $10.3 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $10.4 million in Q4 2025, with the low at $4.6 million in Q4 2021.
- Historically, Depreciation & Amortization (CF) has averaged $7.0 million across 5 years, with a median of $7.0 million in 2023.
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) advanced 3.2% — and 2024, when it surged 48.52%.
- Alvotech's Depreciation & Amortization (CF) stood at $4.6 million in 2021, then gained by 16.11% to $5.3 million in 2022, then gained by 26.29% to $6.7 million in 2023, then rose by 21.26% to $8.2 million in 2024, then advanced by 27.69% to $10.4 million in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $10.4 million (Q4 2025), $10.3 million (Q3 2025), and $8.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 21.95 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 22.68 Mn |
| 10 | Alvotech | 12.16 Mn | -160.20 Mn | -22.39 Mn | 10.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.41 Mn |
| Dec 31, 2025 | 10.41 Mn |
| Sep 30, 2025 | 10.28 Mn |
| Sep 30, 2025 | 10.28 Mn |
| Jun 30, 2025 | 8.90 Mn |
| Jun 30, 2025 | 8.90 Mn |
| Mar 31, 2025 | 8.26 Mn |
| Mar 31, 2025 | 8.26 Mn |
| Dec 31, 2024 | 8.16 Mn |
| Dec 31, 2024 | 8.16 Mn |
| Sep 30, 2024 | 8.40 Mn |
| Sep 30, 2024 | 8.40 Mn |
| Jun 30, 2024 | 7.56 Mn |
| Jun 30, 2024 | 7.56 Mn |
| Mar 31, 2024 | 7.19 Mn |
| Mar 31, 2024 | 7.19 Mn |
| Dec 31, 2023 | 6.73 Mn |
| Dec 31, 2023 | 6.73 Mn |
| Jun 30, 2023 | 6.09 Mn |
| Jun 30, 2023 | 6.09 Mn |